Immix Biopharma Inc (IMMX)

Apr 13, 2026

Immix Biopharma (IMMX) price target increased by 11.73% to 18.62 - MSN

Apr 13, 2026

Apr 13, 2026

Moving Averages: Should I trade or invest in Immix Biopharma IncWall Street Watch & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

IMMX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 12, 2026

Apr 11, 2026

Bear Alert: Is Immix Biopharma Inc in a bullish channel2026 Analyst Calls & Weekly High Conviction Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Guidance Update: Is Immix Biopharma Inc stock a buy or sell2026 Bull vs Bear & Weekly High Conviction Trade Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Immix rises as Morgan Stanley starts with bullish view on CAR-T therapy - MSN

Apr 10, 2026

Apr 10, 2026

Immix Biopharma to Participate in Jefferies Global Healthcare Conference - National Today

Apr 10, 2026

Apr 09, 2026

Immix Biopharma to Host Investor Meetings at Jefferies Global Healthcare Conference 2026 - Quiver Quantitative

Apr 09, 2026

Apr 09, 2026

Immix Biopharma lines up investor meetings at Jefferies event - Stock Titan

Apr 09, 2026

Apr 08, 2026

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference - Bitget

Apr 08, 2026

Apr 06, 2026

Immix Biopharma (IMMX) seeks approval of board slate, auditor and reviews 2025 executive pay - Stock Titan

Apr 06, 2026

Apr 05, 2026

Earnings Recap: Is Immix Biopharma Inc benefiting from innovation trendsNew Guidance & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 03, 2026

Apr 02, 2026

Immix Biopharma Stock Price Forecast. Should You Buy IMMX? - stockinvest.us

Apr 02, 2026

Apr 01, 2026

Citizens Initiates Coverage of Immix Biopharma (IMMX) with Market Outperform Recommendation - MSN

Apr 01, 2026

Apr 01, 2026

IMMX PE Ratio & Valuation, Is IMMX Overvalued - Intellectia AI

Apr 01, 2026

Apr 01, 2026

Immix Biopharma ― NEXICART-2 の進展で勢いが増す - Smartkarma

Apr 01, 2026

Mar 31, 2026

Weekly Earnings: Is Immix Biopharma Inc stock a buy or sell2026 Chart Watch & Daily Entry Point Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Bear Alert: Is Immix Biopharma Inc benefiting from innovation trends2026 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Citizens reiterates Immix Biopharma stock rating on trial enrollment By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Citizens reiterates Immix Biopharma stock rating on trial enrollment - Investing.com

Mar 31, 2026

Mar 31, 2026

Immix Biopharma completes enrollment in AL amyloidosis trial By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 30, 2026

Immix Biopharma (IMMX) price target increased by 25.64% to 16.66 - MSN

Mar 30, 2026

Mar 30, 2026

Immix Biopharma Completes NEXICART-2 Enrollment for NXC-201 - tipranks.com

Mar 30, 2026

Mar 30, 2026

Immix completes enrollment in NEXICART-2; topline results expected Q3 2026 - TradingView

Mar 30, 2026

Mar 30, 2026

[8-K] Immix Biopharma, Inc. Reports Material Event - stocktitan.net

Mar 30, 2026

Mar 30, 2026

Immix Biopharma Completes Enrollment for Key AL Amyloidosis Trial - nationaltoday.com

Mar 30, 2026

Mar 30, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat

Mar 30, 2026

Mar 30, 2026

Immix Biopharma Inc Announces Enrollment Completion Of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2 And Upcoming Milestones - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Immix Biopharma completes enrollment in AL amyloidosis trial - Investing.com

Mar 30, 2026

Mar 30, 2026

Immix Biopharma, Inc. has announced the successful completion of patient enrollment for its Nexicart-2 trial in relapsed/refractory AL amyloidosis, which supports the Biologics License Application (BLA). - Bitget

Mar 30, 2026

Mar 30, 2026

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones - The Manila Times

Mar 30, 2026

Mar 30, 2026

Mizuho raises Immix Biopharma stock price target on cash position By Investing.com - Investing.com India

Mar 30, 2026

Mar 30, 2026

Mizuho raises Immix Biopharma stock price target on cash position - Investing.com

Mar 30, 2026

Mar 28, 2026

Should I trade or invest in Immix Biopharma Inc2026 Breakouts & Breakdowns & Proven Capital Preservation Tips - baoquankhu1.vn

Mar 28, 2026

Mar 28, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Mar 28, 2026

Mar 28, 2026

Immix Biopharma, Inc. 2025 Annual Report Amendment: Financial Statements, Auditor Correction, and Company Overview - Minichart

Mar 28, 2026

Mar 27, 2026

Immix Biopharma (NASDAQ:IMMX) Issues Quarterly Earnings Results - MarketBeat

Mar 27, 2026

Mar 27, 2026

Immix Biopharma (NASDAQ: IMMX) widens 2025 loss but ends year with $100M cash - stocktitan.net

Mar 27, 2026

Mar 27, 2026

Mizuho raises Immix Biopharma stock price target to $15 on cash position - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

Mizuho raises Immix Biopharma stock price target to $15 on cash position By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 27, 2026

Citizens Jmp Reaffirms Market Outperform Rating for Immix Biopharma (NASDAQ:IMMX) - MarketBeat

Mar 27, 2026